Found: 19
Select item for more details and to access through your institution.
Benefits of Early Roflumilast Treatment After Hospital or Emergency Department Discharge for a COPD Exacerbation.
- Published in:
- American Health & Drug Benefits, 2016, v. 9, n. 3, p. 140
- By:
- Publication type:
- Article
Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2015, p. 909, doi. 10.2147/COPD.S83082
- By:
- Publication type:
- Article
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world.
- Published in:
- International Journal of COPD, 2015, p. 2127, doi. 10.2147/COPD.S80106
- By:
- Publication type:
- Article
Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
- Published in:
- International Journal of COPD, 2015, p. 565, doi. 10.2147/COPD.S79025
- By:
- Publication type:
- Article
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world.
- Published in:
- International Journal of COPD, 2015, v. 10, p. 2127, doi. 10.2147/COPD.S80106
- By:
- Publication type:
- Article
Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2015, v. 10, p. 909, doi. 10.2147/COPD.S83082
- By:
- Publication type:
- Article
Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
- Published in:
- International Journal of COPD, 2015, v. 10, p. 565, doi. 10.2147/COPD.S79025
- By:
- Publication type:
- Article
Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally epresentative chart review and patient survey.
- Published in:
- International Journal of COPD, 2014, v. 9, p. 991, doi. 10.2147/COPD.S66798
- By:
- Publication type:
- Article
Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials.
- Published in:
- International Journal of COPD, 2014, v. 9, p. 657, doi. 10.2147/COPD.S55738
- By:
- Publication type:
- Article
Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2013, v. 9, p. 641, doi. 10.2147/COPD.S51245
- By:
- Publication type:
- Article
Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis.
- Published in:
- International Journal of COPD, 2013, v. 8, p. 175, doi. 10.2147/COPD.S40437
- By:
- Publication type:
- Article
Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 757, doi. 10.2147/COPD.S36997
- By:
- Publication type:
- Article
The impact of the Medicare Part D prescription benefit on generic drug use.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 517, doi. 10.2147/JBM.S359510
- By:
- Publication type:
- Article
The Impact of Pharmacokinetic-Guided Prophylaxis on Clinical Outcomes and Healthcare Resource Utilization in Hemophilia A Patients: Real-World Evidence from the CHESS II Study.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 505, doi. 10.2147/JBM.S363028
- By:
- Publication type:
- Article
Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231177023
- By:
- Publication type:
- Article
Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231177294
- By:
- Publication type:
- Article
Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221130334
- By:
- Publication type:
- Article